Streetbeat News

Stock Prices

JYNT

The Joint Corp. has reiterated its guidance for 2024, with system-wide sales expected to range between $530 million and $545 million.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:43 pm

DNMR

Danimer Scientific, Inc. (DNMR) announced a proposed pro-rata distribution of Dividend Warrants to holders of its Common Stock and other eligible recipients, contingent on stockholder approval to increase the authorized shares. The distribution aims to improve balance sheet leverage and strengthen the capital structure, offering stockholders and noteholders a path to capture value through a nondilutive warrant distribution. The Dividend Warrants are expected to list on the OTCQX market post-distribution, with an additional incentive for early exercise.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:42 pm

NSC

The Brotherhood of Locomotive Engineers and Trainmen (BLET) General Chairmen, representing members at Norfolk Southern Corporation (NYSE:NSC), criticized CEO Alan Shaw for his attacks on labor discussions, labeling them as unfounded and desperate. They accused Shaw of misrepresenting discussions with Ancora nominees and the record of Jim Barber, an Ancora nominee with a positive history of union relations at UPS. The BLET leaders, who initially supported Shaw, have shifted their support to Ancora and its nominees due to Shaw's inconsistent strategies and attacks on labor.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:42 pm

LMAT

LeMaitre Vascular forecasts Q2 EPS of $0.45-$0.50, surpassing the $0.44 estimate, with sales between $53.7M-$56.1M, also above the $54.29M estimate. For FY24, the company expects EPS of $1.73-$1.84, exceeding the $1.65 estimate, and sales of $212.7M-$217.3M, surpassing the $211.7M estimate.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:42 pm

TXRH

Texas Roadhouse has reaffirmed its outlook for 2024, projecting positive growth in comparable restaurant sales, which includes the benefits from menu pricing actions.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:41 pm

SEM

The Board of Directors of Select Medical has authorized a common stock repurchase program, allowing the company to repurchase up to $1 billion worth of its common stock. This move indicates the company's confidence in its financial health and future prospects.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:40 pm

STEM

Stem Inc. shares are trading lower following the announcement of disappointing Q1 financial results and a reduction in its FY24 revenue guidance.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:38 pm

SEM

Select Medical Holdings (SEM) reported Q1 earnings of $0.77 per share, surpassing the consensus estimate of $0.57 by 35.09%, and a 37.5% increase from last year's $0.56. Sales reached $1.79B, beating the $1.74B estimate by 2.87%, marking a 7.51% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:38 pm

TRUP

Trupanion reported Q1 2024 earnings with a smaller loss per share of $(0.16) compared to the expected $(0.21), and sales of $306.121M, surpassing the forecast of $300.514M. This represents a significant improvement over the previous year, with a 73.33% decrease in losses per share and a 19.43% increase in sales.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:37 pm

CSTL

Castle Biosciences has raised its FY23 revenue forecast from the previous range of $235M-$240M to a new range of $255M-$265M, surpassing the estimated $237.636M.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:35 pm